Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Gypenoside XLVI | 94705-70-1 | 99.7% | 963.15 g·mol^-1 | C48H82O19 | 10 MG
SDP

Catalog No. 5000289745
Encompass_Preferred

Gypenoside XLVI is a dammarane-type triterpenoid glycoside isolated from Gynostemma species, supplied as a 10 mg research-grade sample for biochemical and pharmacological studies. It has reported inhibitory activity against non-small cell lung carcinoma A549 cells and is intended for laboratory research use only.

  • Natural dammarane-type triterpenoid glycoside
  • Molecular formula C48H82O19 and molecular weight 963.15 g·mol^-1
  • CAS number 94705-70-1
  • High purity (99.7%) suitable for analytical and biological assays
  • Provided as a 10 mg sample for laboratory use
  • For research use only; not for human or clinical use

Catalog No. 50-002-89745 Supplier Medchemexpress LLC Supplier No. HYN625210MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gypenoside XLVI is a dammarane-type triterpenoid glycoside isolated from Gynostemma species, supplied as a 10 mg research-grade sample for biochemical and pharmacological studies. It has reported inhibitory activity against non-small cell lung carcinoma A549 cells and is intended for laboratory research use only.

  • Natural dammarane-type triterpenoid glycoside
  • Molecular formula C48H82O19 and molecular weight 963.15 g·mol^-1
  • CAS number 94705-70-1
  • High purity (99.7%) suitable for analytical and biological assays
  • Provided as a 10 mg sample for laboratory use
  • For research use only; not for human or clinical use

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.